Endometrial Biopsy Cannulae Market by Product Type (Rigid Endometrial Biopsy Cannulae and Flexible Endometrial Biopsy Cannulae), by End User (Hospitals, Diagnostic Centers, Specialty Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis, 2018 – 2026.

An endometrial biopsy is a procedure used for obtaining small and thin section of endometrial tissue, which is the inner most lining of the uterus, for disease detection and testing. Clinically endometrial biopsy cannulae is used for the evaluation of infertility, amenorrhea, uterine cancer, abnormal uterine bleeding or endometrial infection. Endometrial biopsy cannulae are available in varying size. They are effective and affordable small medical devices used for regular diagnostic practice.

Disease detection through biopsy is gaining significant demand owing to its accuracy, which is expected to drive growth of the endometrial biopsy cannulae market growth over the forecast period. For instance, according to the National Cancer Institute, around 85% of endometrial cancer are diagnosed at an earlier stage using endometrial sampling or biopsy. Moreover, increasing incidence of uterus related diseases is driving growth of the endometrial biopsy cannulae market.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/endometrial-biopsy-cannulae-market-1937

Endometrial Biopsy Cannulae Market Dynamics
Increasing incidence of uterine cancer is a major factor propelling demand for endometrial biopsy cannulae. For instance, according to the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program, an estimated 63,230 new cases of cancer were reported in 2018 in the U.S., which is around 26 cases per 100,000 women.

The same source reported that an estimated 2.9% women are expected to have uterine cancer during their lifespan. Therefore, population at a risk of developing cancer frequently undergo cancer diagnosis, which is propelling demand for endometrial biopsy cannulae. According to American Cancer Society’s (ACS) publication, Cancer Facts & Figures 2018, around 92% of uterine cancer are observed in endometrial lining and high prevalence of obesity increases the risk of uterine cancer development proportionally.

Infertility is also diagnosed using biopsy and high prevalence of infertility related issues are also expected to fuel growth of the endometrial biopsy cannulae market over the forecast period. For instance, according to Maternal Health Task Force (MHTF), a project of the Women and Health Initiative at the Harvard T.H. Chan School of Public Health, 2017, nearly 50 million couples across the world experience infertility.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1937

Abnormal uterine bleeding is also a significant clinical condition which is driving demand for endometrial biopsy. According to Best Practice & Research. According to data published by Clinical Obstetrics & Gynaecology in 2016, heavy menstrual bleeding affects 14-25% of women in the reproductive age. Moreover, it states that 800,000 women consult medical professionals for abnormal uterine bleeding annually.

Increasing initiatives to create awareness among population regarding early detection of diseases and the importance of reducing uterine cancer-related morbidity are major factors that are expected to boost growth of the endometrial biopsy cannulae market. For instance, governments and non-governmental organizations organize programs to spread awareness about early detection of cancer and its importance and also recommend periodic health check-ups. Furthermore, consultation with respect to infertility is increasing at a fast pace owing to increasing health awareness among the populace, which, in turn, is propelling the market growth.

Endometritis, a uterine infection, is another common condition in low income economies, which require clinical attention. For instance, according to a study published in the Clinical and Experimental Reproductive Medicine journal in 2016, chronic endometritis affects around 10% of the global population.

However, endometrial biopsy cannulae market growth is expected to be hindered by complications associated with uterine or cervical injury, pelvic infection, vagal reaction, incomplete evacuation, or acute hematometra. Moreover, alternative methods of biopsy such as imagining technics or vaginal fine-needle aspiration is also expected to restrain the market growth.

Endometrial Biopsy Cannulae Market - Regional Analysis
On the basis of region, the global endometrial biopsy cannulae market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America endometrial biopsy cannulae market holds the dominant position in the market owing to increasing uterine cancer incidence. For instance, according to National Cancer Institute, the incidence of uterine cancer increased by 1% per year in the time span of 2005 to 2014 in Caucasian women. However, Asia Pacific and Africa provides good opportunity for the market players to expand their product range to fulfil the unmet medical needs in low income economies.

Major players in the global endometrial biopsy cannulae market include Medline Industries, Inc., CooperSurgical, Inc., MedGyn Products, Inc., Gyneas, Andemed, Nuode, Saipu, Micromed, and Panpac Medical & RI.MOS.

Endometrial Biopsy Cannulae Market Taxonomy:
Based on product type:
• Rigid Endometrial Biopsy Cannulae
• Flexible Endometrial Biopsy Cannulae
Based on end user:
• Hospitals
• Diagnostic Centers
• Specialty Clinics
• Others

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1937

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737